Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis by Yaohong Wen, Shuyi Zhou, Yuyan Xu, Cheng Zhang, Zhoubin Feng, Yinghui Song, Bai Ding, Chuang Peng, Hongkun Tan, Chunming Wang, Jianan Feng, Jingyuan Pei, Guolin He, Shunjun Fu, Lvhuan Wang, Lei Cai, Sulai Liu, Mingxin Pan

Get full text